- Home
- AIRT vs XTNT Comparison
AIRT vs XTNT Comparison
Compare AIRT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- XTNT
- Stock Information
- Founded
- AIRT 1980
- XTNT N/A
- Country
- AIRT United States
- XTNT United States
- Employees
- AIRT N/A
- XTNT N/A
- Industry
- AIRT Air Freight/Delivery Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIRT Consumer Discretionary
- XTNT Health Care
- Exchange
- AIRT Nasdaq
- XTNT Nasdaq
- Market Cap
- AIRT 53.2M
- XTNT 60.9M
- IPO Year
- AIRT N/A
- XTNT N/A
- Fundamental
- Price
- AIRT $22.48
- XTNT $0.62
- Analyst Decision
- AIRT
- XTNT
- Analyst Count
- AIRT 0
- XTNT 0
- Target Price
- AIRT N/A
- XTNT N/A
- AVG Volume (30 Days)
- AIRT 1.1K
- XTNT 48.4K
- Earning Date
- AIRT 06-27-2025
- XTNT 08-07-2025
- Dividend Yield
- AIRT N/A
- XTNT N/A
- EPS Growth
- AIRT N/A
- XTNT N/A
- EPS
- AIRT N/A
- XTNT N/A
- Revenue
- AIRT $291,850,000.00
- XTNT $122,298,000.00
- Revenue This Year
- AIRT N/A
- XTNT $11.64
- Revenue Next Year
- AIRT N/A
- XTNT $7.59
- P/E Ratio
- AIRT N/A
- XTNT N/A
- Revenue Growth
- AIRT 1.75
- XTNT 20.81
- 52 Week Low
- AIRT $14.56
- XTNT $0.33
- 52 Week High
- AIRT $30.60
- XTNT $0.83
- Technical
- Relative Strength Index (RSI)
- AIRT 61.08
- XTNT 48.39
- Support Level
- AIRT $18.86
- XTNT $0.57
- Resistance Level
- AIRT $24.92
- XTNT $0.65
- Average True Range (ATR)
- AIRT 0.91
- XTNT 0.05
- MACD
- AIRT -0.03
- XTNT -0.01
- Stochastic Oscillator
- AIRT 65.92
- XTNT 33.33
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.